x

January 20, 2026

Crown Bioscience San Diego Laboratory Achieves CAP Accreditation, Building on CLIA Certification to Expand Clinical-Grade Capabilities

November 13, 2025

JSR Life Sciences Enters Definitive Agreement to Transfer Crown Bioscience to Adicon Holdings Limited

October 30, 2025

Crown Bioscience Achieves Second CLIA Certification of 2025 at Suzhou Laboratory

October 16, 2025

Crown Bioscience Named Best Preclinical Oncology CRO in the Healthcare and Pharmaceutical Awards 2025

September 17, 2025

Crown Bioscience Expands US Presence with New Model Development Center in Kannapolis, North Carolina

September 11, 2025

Medicines Discovery Catapult and Crown Bioscience Form Strategic Global Alliance for Radiopharmaceutical Innovation

July 22, 2025

Crown Bioscience San Diego Achieves CLIA Certification to Enhance Clinical Trial Support

July 8, 2025

Crown Bioscience Announces Promotion of Alex Slater to Chief Business Officer, Signaling Continued Focus on Commercial Excellence

June 24, 2025

Crown Bioscience Named Fierce CRO Award Winner for Excellence in Global Operations

June 25, 2025

Webinar: Biospecimens & Multi-Omics in Clinically Relevant Research

May 7, 2025

Crown Bioscience Achieves Green Lab Sustainability Certification

May 1, 2025

Crown Bioscience and NEXT Oncology Cement Partnership Extension

Optimising Clinical Trials Through Integrated Biomarker and Translational Data Models

Julie Ann Mayer, PhD

February 9, 2026

Optimising Clinical Trials Through Integrated Biomarker and Translational Data Models

Published in IBI on February 5, 2026, by Julie Ann Mayer, PhD

Cite this Article

Ann, J., (2026) Optimising Clinical Trials Through Integrated Biomarker and Translational Data Models - Crown Bioscience. https://blog.crownbio.com/optimising-clinical-trials-through-integrated-biomarker-and-translational-data-models